Literature DB >> 6715130

Retinal toxicity of intravitreal gentamicin. An electron microscopic study.

D J D'Amico, J Libert, K R Kenyon, L A Hanninen, L Caspers-Velu.   

Abstract

Retinal ultrastructure was examined at various intervals following a single intravitreal injection of 100-4,000 micrograms of gentamicin in rabbit eyes. Three days after injections of 100-500 micrograms, numerous abnormal lamellar lysosomal inclusions were observed in the retinal pigment epithelium (RPE) and in macrophages in the subretinal space. These changes were typical of drug-induced lipid storage and were comparable to inclusions reported in kidney and other tissues as manifestations of gentamicin toxicity. One week after similar injections, focal areas of RPE necrosis and hyperplasia with disruption of outer segments appeared, but the inner segments and inner retina were intact. Doses of 800-4,000 micrograms produced a combined picture of RPE/macrophage lipidosis within the first 3 days, with increasing, superimposed, inner, retinal necrosis. This study provides the first evidence of lysosomal alterations in ocular tissues following the intravitreal injection of gentamicin and implicates the RPE as the primary site of observed toxicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715130

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  The role of preservatives in the conjunctival toxicity of subconjunctival gentamicin injection.

Authors:  M Pande; F Ghanchi
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

2.  2-Phenyl-APB-144-Induced Retinal Pigment Epithelium Degeneration and Its Underlying Mechanisms.

Authors:  Shin-ichiro Hirai; Hiroaki Kurashima; Daisuke Nakamura; Tomoko Komatsu; Yuki Yasuda; Sayo Habashita-Obata; Sanae Ichikawa; Osamu Katsuta; Takao Iwawaki; Kenji Kohno
Journal:  J Ocul Pharmacol Ther       Date:  2015-08-27       Impact factor: 2.671

3.  Topical and intravenous gentamicin in traumatically lacerated eyes.

Authors:  M O Yoshizumi; M J Leinwand; J Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 4.  Nonproliferative and Proliferative Lesions of the Ratand Mouse Special Sense Organs(Ocular [eye and glands], Olfactory and Otic).

Authors:  Meg Ferrell Ramos; Julia Baker; Elke-Astrid Atzpodien; Ute Bach; Jacqueline Brassard; James Cartwright; Cynthia Farman; Cindy Fishman; Matt Jacobsen; Ursula Junker-Walker; Frieke Kuper; Maria Cecilia Rey Moreno; Susanne Rittinghausen; Ken Schafer; Kohji Tanaka; Leandro Teixeira; Katsuhiko Yoshizawa; Hui Zhang
Journal:  J Toxicol Pathol       Date:  2018-07-28       Impact factor: 1.628

Review 5.  Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.

Authors:  G A Stern
Journal:  Trans Am Ophthalmol Soc       Date:  1993

6.  Antibiotics Reduce Retinal Cell Survival In Vitro.

Authors:  Amy E Lindsey; Ellen Townes-Anderson
Journal:  Neurotox Res       Date:  2017-11-02       Impact factor: 3.911

7.  Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.

Authors:  S K Moestrup; S Cui; H Vorum; C Bregengård; S E Bjørn; K Norris; J Gliemann; E I Christensen
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

8.  Retinotoxicity of 1,4,-bis(4-aminophenoxy)-2-phenylbenzene (2-phenyl-APB-144) in albino and pigmented rats.

Authors:  K P Lee; R Valentine
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

9.  Pathogenesis and reversibility of retinopathy induced by 1,4-bis (4-aminophenoxy)-2-phenylbenzene (2-phenyl-APB-144) in pigmented rats.

Authors:  K P Lee; R Valentine
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

10.  Retinal toxicity of antibiotics: evaluation by electroretinogram.

Authors:  K Mochizuki; M Torisaki; K Kawasaki; Y Shirao; Y Yamashita; K Kitano; D Yonemura
Journal:  Doc Ophthalmol       Date:  1988-06       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.